HDA UK Media And Political Bulletin – 12 May 2017

Media Summary

World Health Organization tries moving closer to creating a ‘fair pricing’ model
STAT, Ed Silverman, 11 May 2017

After consultation with drug makers, advocacy groups, and government agencies, World Health Organization officials say they are gradually moving closer to a framework for fair pricing of prescription medicines. The Fair Pricing Forum was hosted by the government of the Netherlands, and was attended by over 200 invited stakeholders. However, Marie-Paule Kieny, assistant director general for health systems and innovation at the WHO emphasised: “By fair pricing, we don’t mean low pricing”. The Forum concluded with a strong stance against value-based pricing, which was said not to have improved access to medicines around the world.

MHRA Inspectorate Organogram
MHRA Inspectorate Blog, Mark Birse, 11 May 2017

The MHRA Inspectorate Blog has been updated to provide access to the MHRA Inspectorate organogram. This follows the March 2017 GMP-GDP Consultative Committee meeting where it was raised that many members would find it beneficial to access it. The GMP-GDP Consultative Committee is an informal committee established to discuss matters relating to the manufacture and wholesale distribution of medicines for human use between the MHRA, other governmental departments, the devolved administrations and relevant trade associations.

Parliamentary Coverage

There is no Parliamentary Coverage.

Full Coverage

MHRA Inspectorate Organogram
MHRA Inspectorate Blog, Mark Birse, 11 May 2017

We have today updated the sidebar of the MHRA Inspectorate Blog to provide access to the MHRA Inspectorate organogram.

At the March 2017 GMP-GDP Consultative Committee meeting we took an action to publish the MHRA Inspectorate Organogram as many members stated they found it useful and wished to be able to access it.

The GMP and GDP Consultative Committee is an informal committee established to discuss matters relating to the manufacture and wholesale distribution of medicines for human use between:

the Medicines and Healthcare products Regulatory Agency (MHRA)
other governmental departments
the devolved administrations
relevant trade associations

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?